Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.23 - $0.46 $15,684 - $31,368
-68,193 Closed
0 $0
Q1 2022

Aug 11, 2023

BUY
$0.3 - $0.61 $20,457 - $41,597
68,193 New
68,193 $29,000
Q1 2022

May 20, 2022

SELL
$0.3 - $0.61 $14,487 - $29,456
-48,290 Reduced 41.46%
68,193 $29,000
Q4 2021

Feb 16, 2022

SELL
$0.55 - $1.04 $16,498 - $31,197
-29,998 Reduced 20.48%
116,483 $64,000
Q3 2021

Nov 12, 2021

BUY
$1.06 - $1.52 $16,629 - $23,845
15,688 Added 11.99%
146,481 $155,000
Q2 2021

Aug 12, 2021

BUY
$1.22 - $1.65 $5,603 - $7,578
4,593 Added 3.64%
130,793 $197,000
Q1 2021

May 03, 2021

BUY
$1.18 - $2.62 $6,931 - $15,389
5,874 Added 4.88%
126,200 $194,000
Q4 2020

Feb 12, 2021

BUY
$1.05 - $2.24 $92,807 - $197,989
88,388 Added 276.75%
120,326 $126,000
Q3 2020

Nov 09, 2020

BUY
$1.7 - $6.41 $54,294 - $204,722
31,938 New
31,938 $65,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $23.8M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.